drugset / Trial / NCT01437722

Dose-ranging Study of SPL7013 Gel for the Prevention of Bacterial Vaginosis (BV)

NCT01437722

Phase 2 Completed 205 enrolled Starpharma Pty Ltd
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose in this clinical study is to determine the efficacy of SPL7013 Gel for the prevention of recurrence of bacterial vaginosis.

Timeline

Start
2011-08
Primary completion
2012-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject SPL7013 Other / unclassified 1 % Other
Subject SPL7013 Other / unclassified 3 % Other

Indications